other material
confidence high
sentiment neutral
materiality 0.50
Glucotrack announces $3.1M public offering of 169,388 shares at $2.04 and pre-funded warrants
Glucotrack, Inc.
- Priced 169,388 common shares at $2.04 plus pre-funded warrants for 1,350,220 shares at $2.039.
- Gross proceeds expected ~$3.1M; net proceeds to repay existing debt, remainder for working capital.
- Placement agent Dawson James Securities; 8% cash fee; closing expected Sept 25, 2026.
- Directors/officers subject to 90-day lock-up; company restricted on new equity issuances for 6 months.